3-Pyridinemethanamine → 4-(5-bromoimidazo[1,2-a]pyrazin-8-ylamino)-N-pyridin-3-ylmethyl benzamide

HRID 1366128

반응식

HRID 1366128 반응식
OC1C=CC(CNC(=O)C2C=CC(NC3C4[N:18]([CH:27]=[CH:28]N=4)[C:19]([C:22]4[CH:23]=[N:24]N[CH:26]=4)=CN=3)=CC=2)=CC=1.[Br:33][C:34]1[N:39]2[CH:40]=[CH:41][N:42]=[C:38]2[C:37]([NH:43][C:44]2[CH:52]=[CH:51][C:47]([C:48]([OH:50])=O)=[CH:46][CH:45]=2)=[N:36][CH:35]=1.NCC1C=NC=CC=1.C(N(CC)C(C)C)(C)C.F[P-](F)(F)(F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2N=CC=CC=2N=N1>CN(C=O)C>[Br:33][C:34]1[N:39]2[CH:40]=[CH:41][N:42]=[C:38]2[C:37]([NH:43][C:44]2[CH:45]=[CH:46][C:47]([C:48]([NH:24][CH2:23][C:22]3[CH:19]=[N:18][CH:27]=[CH:28][CH:26]=3)=[O:50])=[CH:51][CH:52]=2)=[N:36][CH:35]=1

참가 물질

7

반응물 5

HCID 310183-PyridinemethanamineHCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 24857547N-(4-Hydroxybenzyl)-4-[5-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-ylamino]benzamideHCID 582288294-(5-Bromoimidazo[1,2-a]pyrazin-8-ylamino) benzoic acid

생성물 1

HCID 866167454-(5-bromoimidazo[1,2-a]pyrazin-8-ylamino)-N-pyridin-3-ylmethyl benzamide

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

In the same way as described for Compound 90, step 3, using 4-(5-bromoimidazo[1,2-a]pyrazin-8-ylamino) benzoic acid (365 mg, 1.57 mmol), 3-aminomethylpyridine (0.16 mL, 1.57 mmol), N,N-diisopropylethylamine (0.42 mL, 2.35 mmol), O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HATU) (715 mg, 1.9 mmol) and DMF (6mL). The crude residue is purified using column chromatography, eluting with EtOAc followed by EtOAc:MeOH (95:5) then EtOAc:NH3 (7M in MeOH). The title amide is isolated as a solid.

후처리

  1. customThe crude residue is purified
  2. washeluting with EtOAc

출처 및 근거

ORD 기록
ord-d6037040928148d39b0bfc7ed0d06215
출처 데이터셋
uspto-grants-2011_02
특허 번호
US07893058B2

연결된 노트

불러오는 중…